Y-mAbs Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 4.24 M | $33.17 M | 3.67% | 9.49% |
| BLACKROCK, INC. | 02/07/2025 | 3.00 M | $23.48 M | -0.88% | 6.72% |
| 02/14/2025 | 2.86 M | $22.41 M | 100.00% | 6.41% | |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 2.19 M | $17.18 M | 0.00% | 4.92% |
| VANGUARD GROUP INC | 02/11/2025 | 2.00 M | $15.66 M | -1.74% | 4.48% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.83 M | $14.34 M | 0.00% | 4.10% |
| CALIGAN PARTNERS LP | 02/14/2025 | 1.77 M | $13.84 M | 47.92% | 3.96% |
| STATE STREET CORP | 02/14/2025 | 1.31 M | $10.29 M | 8.65% | 2.95% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 1.00 M | $7.83 M | 25.00% | 2.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 822,309 | $6.44 M | 1.08% | 1.84% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 756,297 | $5.92 M | 9.93% | 1.69% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 693,693 | $5.43 M | 24.45% | 1.55% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 615,131 | $4.82 M | -21.89% | 1.38% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 463,235 | $3.63 M | -3.02% | 1.04% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 425,000 | $3.33 M | -70.69% | 0.95% |
| NORTHERN TRUST CORP | 02/14/2025 | 359,223 | $2.81 M | 6.50% | 0.80% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 349,982 | $2.74 M | -12.50% | 0.78% |
| MORGAN STANLEY | 02/14/2025 | 320,807 | $2.51 M | 28.98% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 284,540 | $2.23 M | 1.78% | 0.64% |
| CITADEL ADVISORS LLC | 02/14/2025 | 221,914 | $1.74 M | -19.17% | 0.50% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 219,175 | $1.72 M | -1.54% | 0.49% |
| 02/26/2025 | 155,529 | $1.22 M | 100.00% | 0.35% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 149,681 | $1.17 M | 0.00% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 133,263 | $1.04 M | -2.52% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 131,600 | $1.03 M | 371.68% | 0.29% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 127,159 | $995,655 | 59.51% | 0.28% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 112,483 | $880,742 | 0.00% | 0.25% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 108,549 | $849,939 | -0.12% | 0.24% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 102,968 | $806,239 | -33.54% | 0.23% |
| JPMORGAN CHASE & CO | 02/12/2025 | 97,660 | $764,678 | 221.94% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 92,449 | $723,875 | 0.98% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 88,337 | $691,679 | 31.57% | 0.20% |
| BARCLAYS PLC | 02/13/2025 | 75,862 | $594,000 | 9.59% | 0.17% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 73,900 | $578,637 | -13.06% | 0.17% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 67,367 | $527,484 | 0.12% | 0.15% |
| SWISS NATIONAL BANK | 02/10/2025 | 60,300 | $472,149 | 0.00% | 0.14% |
| ROYAL BANK OF CANADA | 02/14/2025 | 55,677 | $436,000 | 437.94% | 0.12% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 54,780 | $428,927 | 0.00% | 0.12% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 52,356 | $409,948 | 17.41% | 0.12% |
| FMR LLC | 02/13/2025 | 51,722 | $404,983 | 42.03% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 51,452 | $402,859 | -1.65% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 49,900 | $390,717 | -34.34% | 0.11% |
| CITIGROUP INC | 02/12/2025 | 49,231 | $385,479 | 79.94% | 0.11% |
| MARSHALL WACE, LLP | 02/13/2025 | 49,225 | $385,432 | 217.40% | 0.11% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 48,011 | $375,927 | 100.00% | 0.11% |
| FEDERATED HERMES, INC. | 02/13/2025 | 44,474 | $348,231 | 0.00% | 0.10% |
| SAPIENT CAPITAL LLC | 01/29/2025 | 43,700 | $342,171 | 0.00% | 0.10% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 41,255 | $323,027 | 17.61% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 38,932 | $304,838 | -12.68% | 0.09% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 37,857 | $296,420 | -32.00% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Y-mAbs Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 129 institutional investors and hedge funds held shares of Y-mAbs Therapeutics, Inc.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
Paradigm Biocapital Advisors LP: 4.24 M
BlackRock, Inc.: 3 M
Sofinnova Investments, Inc.: 2.19 M
VANGUARD GROUP INC: 2 M
Polar Capital Holdings Plc: 1.83 M
64.43% of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.51 M shares in the last 24 months. This purchase volume represents approximately $133.97 M in transactions.